Work

Cardiogenic shock phenotypes and outcomes under percutaneous left ventricular support: results from a 9-year single-center real-world cohort

Year: 2026
Type: article
Study design: Observational Study
Abstract: BACKGROUND: Refractory cardiogenic shock (CS) remains associated with unacceptably high mortality despite advances in intensive-care and coronary intervention strategies. Percutaneous left ventricular support using Impella is widely used, yet real-world outcomes may differ substantially by underlying shock etiology and phenotype. METHODS: We performed a retrospective single-center cohort study of adults treated with Impella 2.5/CP for refractory CS over a 9-year period. Patients were classified as acute coronary syndrome (ACS), dilated cardiomyopathy (DCM)/myocarditis, severe aortic stenosis (AS), sepsis-associated CS, or other causes. Endpoints were all-cause in-hospital and 12-month mortality. Multivariable logistic regression adjusted for age, sex, lactate, vasoactive score, Impella type was conducted; a sensitivity model additionally included creatinine. RESULTS: Among 409 patients (mean age 69.99 ± 11.56 years; 75.6% male), ACS was the leading phenotype (n = 269), followed by DCM/myocarditis (n = 53), AS (n = 32), sepsis-associated CS (n = 36), and other causes (n = 19). Impella CP was used in 227 patients (55.5%). Overall in-hospital mortality was 48.9% and differed across phenotypes, being highest in sepsis-associated CS (80.6%; chi-squared p < 0.001). Sepsis remained independently associated with in-hospital death after adjustment (adjusted odds ratio 4.65, 95% CI 2.03-12.07, p = 0.0006) for major confounders; finding was consistent after additional adjustment for creatinine (adjusted odds ratio 4.17, 95% CI 1.63-12.26, p = 0.0023). Major bleeding occurred in 14.9%, limb ischemia in 11.7%, pseudoaneurysm in 4.9%, and stroke in 1.0% of the patients. Twelve-month survival analysis also demonstrated phenotype-dependent patterns (log-rank p < 0.01). CONCLUSION: In refractory CS treated with Impella outcomes are strongly phenotype-dependent. Sepsis-associated CS represents an extreme-risk phenotype with poor short- and long-term survival, suggesting phenotype-guided patient selection and prospective validation of escalation strategies.
Language: English
Field: Medicine
Open Access status: hybrid
Estimated APC paid: $4,190
OpenAlex ID: W7236696423
FWCI:
Cites: 28
Cited by:
Related to: 10